← Open Payments lookup

NORMAN DAMRON: Open Payments

NPI 1275034845 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 39 payments from 21 companies in 2025. Trend: 2023 $250 · 2024 $299 · 2025 $870

Food & beverage: $870
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation5$113
Janssen Biotech, Inc.5$94
Merck Sharp & Dohme LLC5$84
Takeda Pharmaceuticals U.S.A., Inc.3$69
Syndax Pharmaceuticals, Inc.2$57
Daiichi Sankyo Inc.2$54
ABBVIE INC.2$46
Blueprint Medicines Corporation1$37
Geron Corporation1$32
Genmab U.S., Inc.1$30

Products named: KISQALI, KEYTRUDA, CARVYKTI, AYVAKIT, RYTELO, RYBREVANT, Epkinly, Orserdu.

Industry payments across IN — which companies pay providers there.